Royal Bank Of Canada Inmune Bio, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 20,627 shares of INMB stock, worth $150,577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,627
Previous 62,086
66.78%
Holding current value
$150,577
Previous $334,000
71.26%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding INMB
# of Institutions
89Shares Held
6.93MCall Options Held
240KPut Options Held
74.6K-
Vanguard Group Inc Valley Forge, PA827KShares$6.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$5.93 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$5.93 Million1.52% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.35 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$2.79 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $131M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...